Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Henry Schein, Inc.
  6. Summary
    HSIC   US8064071025

HENRY SCHEIN, INC.

(HSIC)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/19/2021 11/22/2021 11/23/2021 11/24/2021 11/26/2021 Date
76.14(c) 76.21(c) 76.9(c) 75.9(c) 73.64(c) Last
552 350 483 910 563 100 579 761 687 369 Volume
-1.08% +0.09% +0.91% -1.30% -2.98% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 12 197 M - -
Net income 2021 608 M - -
Net Debt 2021 422 M - -
P/E ratio 2021 17,1x
Yield 2021 -
Sales 2022 12 513 M - -
Net income 2022 649 M - -
Net cash position 2022 105 M - -
P/E ratio 2022 15,8x
Yield 2022 -
Capitalization 10 212 M 10 212 M -
EV / Sales 2021 0,87x
EV / Sales 2022 0,81x
Nbr of Employees 21 000
Free-Float 98,7%
More Financials
Company
Henry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental and medical practitioners. The CompanyÔÇÖs segments include Health care distribution and Technology and value-added services. The Health care distribution segment distributes consumable products, laboratory products, equipment repair services, vaccines, surgical products, diagnostic tests, infection-control products... 
More about the company
Ratings of Henry Schein, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about HENRY SCHEIN, INC.
11/22Henry Schein Unveils New Offerings for Dental Care Professionals
MT
11/22Henry Schein Announces Lineup of New Products and Solutions at the Greater New York Den..
BU
11/22Henry Schein, Inc. Announces Lineup of New Products and Solutions At the Greater New Yo..
CI
11/17Henry Schein Announces Participation in Virtual Conferences in December
BU
11/16Henry Schein Cares Foundation Launches Third Phase of ‘Wearing Is Caring' Campaig..
BU
11/09Henry Schein, Inc. Provides Earnings Guidance for the Year 2022
CI
11/05UBS Adjusts Price Target on Henry Schein to $77 From $72, Maintains Sell Rating
MT
11/04Zimbis Announces New Partnership and Launch of Order Integration with Southern Anesthes..
PR
11/03Baird Adjusts Henry Schein's Price Target to $98 From $94, Reiterates Outperform Rating
MT
11/03Goldman Sachs Adjusts Henry Schein's Price Target to $91 From $88, Maintains Buy Rating
MT
11/03Piper Sandler Adjusts Henry Schein's Price Target to $98 From $95, Reiterates Overweigh..
MT
11/02HENRY SCHEIN INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
11/02Tranche Update on Henry Schein, Inc.'s Equity Buyback Plan announced on December 13, 20..
CI
11/02Henry Schein Reports Higher Q3 Results, Lifts 2021 Adjusted EPS Forecast
MT
11/02Press Release Exhibit A
PU
More news
News in other languages on HENRY SCHEIN, INC.
11/09Henry Schein, Inc. fournit des prévisions de résultats pour l'année 2022
11/02Henry Schein annonce des résultats plus élevés au troisième trimestre et revoit à la ha..
11/02Earnings Flash (HSIC) HENRY SCHEIN annonce un chiffre d'affaires de 3,2 milliards de do..
03/25HENRY SCHEIN : asocia con la Black Coalition Against COVID-19 para intensificar su comprom..
2019USA/OPIOÏDES : J&J va verser 20 million de dollars pour éviter un procès fédéral
More news
Analyst Recommendations on HENRY SCHEIN, INC.
More recommendations
Chart HENRY SCHEIN, INC.
Duration : Period :
Henry Schein, Inc. Technical Analysis Chart | HSIC | US8064071025 | MarketScreener
Technical analysis trends HENRY SCHEIN, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Last Close Price 73,64 $
Average target price 85,91 $
Spread / Average Target 16,7%
EPS Revisions
Managers and Directors
Stanley M. Bergman Chairman & Chief Executive Officer
James P. Breslawski Vice Chairman & President
Steven Paladino Chief Financial Officer, Director & Executive VP
Christopher Pendergast Chief Technology Officer & Senior Vice President
Gerald A. Benjamin Director, Chief Administrative Officer & EVP
Sector and Competitors
1st jan.Capi. (M$)
HENRY SCHEIN, INC.10.14%10 212
CANTEL MEDICAL CORP.1.91%3 343
OWENS & MINOR, INC.57.56%3 216
AS ONE CORPORATION-18.70%2 366
SHIP HEALTHCARE HOLDINGS, INC.-10.80%2 131
TOKAI CORP.-0.69%628